Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
6.77
-0.13 (-1.88%)
At close: May 15, 2026, 4:00 PM EDT
6.82
+0.05 (0.74%)
After-hours: May 15, 2026, 7:56 PM EDT
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 16 analysts that cover Wave Life Sciences stock have a consensus rating of "Strong Buy" and an average price target of $28.88, which forecasts a 326.59% increase in the stock price over the next year. The lowest target is $13 and the highest is $50.
Price Target: $28.88 (+326.59%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Wave Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 7 | 8 | 8 |
| Buy | 8 | 8 | 8 | 9 | 8 | 8 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $30 → $24 | Strong Buy | Maintains | $30 → $24 | +254.51% | May 4, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $52 → $43 | Strong Buy | Maintains | $52 → $43 | +535.16% | Apr 30, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $50 → $15 | Strong Buy | Maintains | $50 → $15 | +121.57% | Apr 29, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $18 | Strong Buy | Maintains | $30 → $18 | +165.88% | Apr 14, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $38 → $21 | Strong Buy | Maintains | $38 → $21 | +210.19% | Mar 27, 2026 |
Financial Forecast
Revenue This Year
50.44M
from 42.73M
Increased by 18.04%
Revenue Next Year
74.58M
from 50.44M
Increased by 47.87%
EPS This Year
-1.01
from -1.21
EPS Next Year
-1.27
from -1.01
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 104.0M | 170.4M | ||||||
| Avg | 50.4M | 74.6M | ||||||
| Low | n/a | 9.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 143.3% | 237.9% | ||||||
| Avg | 18.0% | 47.9% | ||||||
| Low | - | -80.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.72 | -0.23 | ||||||
| Avg | -1.01 | -1.27 | ||||||
| Low | -1.43 | -1.71 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.